Life Sciences
SetPoint Medical Raises $80M to Advance Platform for Autoimmune Diseases
What You Should Know: – Today, SetPoint Medical announced $80M in Series C equity and $65M led by new investors, Norwest Venture Partners and Viking…
What You Should Know:
– Today, SetPoint Medical announced $80M in Series C equity and $65M led by new investors, Norwest Venture Partners and Viking Global Investors, with debt financing provided by Runway Growth Capital.
– The company is developing its novel platform for the treatment of chronic, inflammation-mediated autoimmune diseases and is initially focused on a potentially less immunosuppressive option for the treatment of rheumatoid arthritis (RA). More than 1.5 million people in the U.S. have RA. For those who can’t tolerate or get relief from today’s treatment options, including biologics, SetPoint’s personalized neuroimmune modulation approach has potential to bring relief.
– The company plans to use the funding to complete the company’s ongoing pivotal trial, subsequent FDA regulatory submissions and early commercialization for its device-based therapy for autoimmune diseases such as RA. The RESET-RA study is a multicenter, double-blind, randomized, sham-controlled pivotal trial evaluating SetPoint Medical’s platform for treatment of RA. It will enroll up to 250 patients across 40 U.S. study sites.
Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…
Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…
Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….